L. Nayak

机构：Center for Neuro-Oncology, Dana-Farber Cancer Institute

发表论文 11 篇 · 总被引 47 次 · h-index 3

代表论文

Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab (2014 · Neuro-Oncology · 被引 36)
NEURO/MEDICAL ONCOLOGY (2013 · Neuro-Oncology · 被引 8)
Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study (2026 · Blood · 被引 3)
Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trial (2026 · Nature Communications)
POSTER: ABCL-086: Trial in Progress (IGNITE): A Phase 3, Multiregional, Open-Label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide in Relapsed/Refractory Primary Central Nervous System Lymphoma (2026 · Clinical Lymphoma Myeloma & Leukemia)
ABCL-086: Trial in Progress (IGNITE): A Phase 3, Multiregional, Open-Label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide in Relapsed/Refractory Primary Central Nervous System Lymphoma (2026 · Clinical Lymphoma Myeloma & Leukemia)